Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3-Avadel Pharmaceuticals plc

6th Jan 2026 11:40

RNS Number : 8526N
Bank of America Merrill Lynch
06 January 2026
 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Bank of America Corporation

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

AVADEL PHARMACEUTICALS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

05/01/2026

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

 

 

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

1,829,454

1.878%

548,322

0.563%

(2) Cash-settled derivatives

501,932

0.515%

490,358

0.503%

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0.000%

0

0.000%

Total

2,331,386

2.394%

1,038,680

1.066%

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Purchase

348

21.46 USD

USD 0.01 common

Purchase

53

21.460567 USD

USD 0.01 common

Purchase

60

21.460667 USD

USD 0.01 common

Purchase

78

21.461026 USD

USD 0.01 common

Purchase

41

21.465366 USD

USD 0.01 common

Purchase

33

21.465455 USD

USD 0.01 common

Purchase

40

21.4655 USD

USD 0.01 common

Purchase

41

21.466342 USD

USD 0.01 common

Purchase

45

21.466445 USD

USD 0.01 common

Purchase

3

21.466667 USD

USD 0.01 common

Purchase

46

21.469348 USD

USD 0.01 common

Purchase

57

21.469825 USD

USD 0.01 common

Purchase

63

21.47 USD

USD 0.01 common

Purchase

50

21.4752 USD

USD 0.01 common

Purchase

46

21.475435 USD

USD 0.01 common

Purchase

77

21.475455 USD

USD 0.01 common

Purchase

58

21.476725 USD

USD 0.01 common

Purchase

53

21.476793 USD

USD 0.01 common

Purchase

55

21.477455 USD

USD 0.01 common

Purchase

16

21.4775 USD

USD 0.01 common

Purchase

81

21.477655 USD

USD 0.01 common

Purchase

48

21.477917 USD

USD 0.01 common

Purchase

57

21.478246 USD

USD 0.01 common

Purchase

62

21.48 USD

USD 0.01 common

Purchase

17

21.485295 USD

USD 0.01 common

Purchase

15

21.486 USD

USD 0.01 common

Purchase

17

21.487059 USD

USD 0.01 common

Purchase

20

21.489 USD

USD 0.01 common

Purchase

266

21.49 USD

USD 0.01 common

Purchase

79

21.491013 USD

USD 0.01 common

Purchase

51

21.491177 USD

USD 0.01 common

Purchase

1,106

21.491203 USD

USD 0.01 common

Purchase

49

21.492449 USD

USD 0.01 common

Purchase

43

21.493489 USD

USD 0.01 common

Purchase

79

21.493545 USD

USD 0.01 common

Purchase

17

21.494706 USD

USD 0.01 common

Purchase

146

21.495 USD

USD 0.01 common

Purchase

55

21.495091 USD

USD 0.01 common

Purchase

37

21.495136 USD

USD 0.01 common

Purchase

39

21.495385 USD

USD 0.01 common

Purchase

37

21.495406 USD

USD 0.01 common

Purchase

11

21.495455 USD

USD 0.01 common

Purchase

38

21.495527 USD

USD 0.01 common

Purchase

22

21.49591 USD

USD 0.01 common

Purchase

21

21.496191 USD

USD 0.01 common

Purchase

19

21.496316 USD

USD 0.01 common

Purchase

18

21.496667 USD

USD 0.01 common

Purchase

731

21.499494 USD

USD 0.01 common

Purchase

42

21.5 USD

USD 0.01 common

Purchase

14

21.505 USD

USD 0.01 common

Purchase

11

21.51 USD

USD 0.01 common

Purchase

15

21.52 USD

USD 0.01 common

Purchase

77

21.5 USD

 

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Sale

36

21.47 USD

USD 0.01 common

Sale

68

21.48 USD

USD 0.01 common

Sale

61

21.49 USD

USD 0.01 common

Sale

1,129

21.490904 USD

USD 0.01 common

Sale

122

21.495 USD

USD 0.01 common

Sale

27

21.495186 USD

USD 0.01 common

Sale

20

21.496 USD

USD 0.01 common

Sale

155

21.5 USD

USD 0.01 common

Sale

76

21.51 USD

USD 0.01 common

Sale

15

21.52 USD

USD 0.01 common

Sale

10

21.5 USD

USD 0.01 common

Sale

10

21.495 USD

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

 USD

USD 0.01 common

Swaps

Reducing a short position

295

21.4907 USD

USD 0.01 common

Swaps

Increasing a short position

1106

21.4914 USD

USD 0.01 common

Swaps

Increasing a long position

9

21.498 USD

USD 0.01 common

Swaps

Reducing a long position

1

21.5 USD

USD 0.01 common

Swaps

Increasing a short position

731

21.4997 USD

USD 0.01 common

Swaps

Reducing a short position

834

21.4907 USD

 

 

(c) Stock-settled derivative transactions (including options)

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

No

 

Date of disclosure

06/01/2026

Contact name

Kamil Dziedzic

Telephone number

+353 86 168 4821

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPFQLFBQFLXBBV
FTSE 100 Latest
Value10,044.69
Change-3.52